{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:08:04Z","timestamp":1790863684676,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jceh.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,3,7]],"date-time":"2015-03-07T00:30:20Z","timestamp":1425688220000},"page":"51-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":168,"title":["Non-alcoholic Fatty Liver Disease and Metabolic Syndrome\u2014Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology"],"prefix":"10.1016","volume":"5","author":[{"given":"Ajay","family":"Duseja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivaram P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek A.","family":"Saraswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrat K.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh K.","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhankar","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha K.","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohinivilasam V.","family":"Jayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushal","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri P.","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrudananda","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arumugam","family":"Muruganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banshi","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Sahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2015.02.006_bib1","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1007\/s00125-011-2291-5","article-title":"Prevalence of diabetes and prediabetes (impaired fasting glucose and\/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdiaDIABetes (ICMR-INDIAB) study","volume":"54","author":"Anjana","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.jceh.2015.02.006_bib2","series-title":"Diabetes Atlas","author":"International Diabetes Federation","year":"2011"},{"key":"10.1016\/j.jceh.2015.02.006_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.jhh.1001633","article-title":"Trends in hypertension epidemiology in India","volume":"18","author":"Gupta","year":"2004","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.jceh.2015.02.006_bib4","doi-asserted-by":"crossref","first-page":"409083","DOI":"10.1155\/2013\/409083","article-title":"The rising burden of diabetes and hypertension in southeast asian and african regions: need for effective strategies for prevention and control in primary health care settings","volume":"2013","author":"Mohan","year":"2013","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.jceh.2015.02.006_bib5","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.3390\/nu5072708","article-title":"Obesity and dyslipidemia in South Asians","volume":"5","author":"Misra","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.jceh.2015.02.006_bib6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nut.2004.01.020","article-title":"Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications","volume":"20","author":"Misra","year":"2004","journal-title":"Nutrition"},{"key":"10.1016\/j.jceh.2015.02.006_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/met.2004.2.14","article-title":"The metabolic syndrome in Asian-Indians: impact of nutritional and socio-economic transition in India","volume":"2","author":"Wasir","year":"2004","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jceh.2015.02.006_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/1540419031361390","article-title":"Asian Indians and insulin resistance syndrome: global perspective","volume":"1","author":"Misra","year":"2003","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jceh.2015.02.006_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/met.2009.0024","article-title":"The metabolic syndrome in South Asians: epidemiology, determinants, and prevention","volume":"7","author":"Misra","year":"2009","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jceh.2015.02.006_bib10","first-page":"279","article-title":"Metabolic correlates of non-alcoholic fatty liver disease and management issues: a perspective for Asian Indians","volume":"1","author":"Luthra","year":"2007","journal-title":"Diabetes Metab Syndr Res Rev"},{"key":"10.1016\/j.jceh.2015.02.006_bib11","first-page":"285","article-title":"A\u00a0case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease","volume":"129","author":"Bajaj","year":"2009","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jceh.2015.02.006_bib12","doi-asserted-by":"crossref","first-page":"18273","DOI":"10.1073\/pnas.0608537103","article-title":"Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men","volume":"103","author":"Petersen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jceh.2015.02.006_bib13","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1056\/NEJMoa0907295","article-title":"Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease","volume":"362","author":"Petersen","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2015.02.006_bib14","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1440-1746.2012.07103.x","article-title":"APOC3 and PNPLA3 in non-alcoholic fatty liver disease: need to clear the air","volume":"27","author":"Duseja","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib15","first-page":"142","article-title":"Nonalcoholic fatty liver disease in India - is it different?","volume":"27","author":"Duseja","year":"2006","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib16","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1007\/s10620-006-9136-y","article-title":"The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West","volume":"52","author":"Duseja","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2015.02.006_bib17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3748\/wjg.v13.i4.649","article-title":"Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation","volume":"13","author":"Duseja","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12664-010-0069-1","article-title":"Nonalcoholic fatty liver disease in India \u2013 a lot done, yet more required!","volume":"29","author":"Duseja","year":"2010","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1440-1746.2003.03252.x","article-title":"Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?","volume":"19","author":"Chitturi","year":"2004","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib20","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.3748\/wjg.v13.i47.6419","article-title":"Prevalence of fatty liver disease and its risk factors in the population of South China","volume":"13","author":"Zhou","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib21","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jhep.2008.11.021","article-title":"Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study","volume":"50","author":"Li","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1291\/hypres.24.337","article-title":"Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan","volume":"24","author":"Akahoshi","year":"2001","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jceh.2015.02.006_bib23","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/00007611-200406000-00013","article-title":"Which anthropometric indices best predict metabolic disorders in Taiwan?","volume":"97","author":"Lai","year":"2004","journal-title":"South Med J"},{"key":"10.1016\/j.jceh.2015.02.006_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/dmrr.924","article-title":"The roles of obesity and gender on the relationship between metabolic risk factors and non-alcoholic fatty liver disease in Koreans","volume":"25","author":"Lee","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jceh.2015.02.006_bib25","first-page":"76","article-title":"Prevalence of non-alcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey","volume":"25","author":"Singh","year":"2004","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1665-2681(19)31922-2","article-title":"Prevalence of non-alcoholic fatty liver disease: population based study","volume":"6","author":"Amarapurkar","year":"2007","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.diabres.2008.11.039","article-title":"Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome","volume":"84","author":"Mohan","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jceh.2015.02.006_bib28","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.23567","article-title":"Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease","volume":"51","author":"Das","year":"2010","journal-title":"Hepatology"},{"issue":"suppl l","key":"10.1016\/j.jceh.2015.02.006_bib29","first-page":"A402","article-title":"Nonalcoholic fatty liver disease in patients with recent onset type 2 diabetes mellitus (abstract)","volume":"19","author":"Duseja","year":"2004","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib30","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1440-1746.2004.03312.x","article-title":"Non-alcoholic steatohepatitis in type 2 diabetes mellitus","volume":"19","author":"Gupte","year":"2004","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib31","first-page":"1","article-title":"Nonalcoholic fatty liver disease in India \u2013 how much? How soon?","volume":"26","author":"Duseja","year":"2005","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2015.02.006_bib33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2015.02.006_bib34","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2015.02.006_bib35","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1001\/jama.289.22.3000","article-title":"Nonalcoholic fatty liver disease: an under-recognized cause of cryptogenic cirrhosis","volume":"289","author":"Clark","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2015.02.006_bib36","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510290347","article-title":"Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease","volume":"29","author":"Caldwell","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2015.02.006_bib37","first-page":"3","article-title":"Chronic liver disease in diabetes mellitus","volume":"23","author":"Amarapurkar","year":"2002","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib38","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/hep.23838","article-title":"Nonalcoholic fatty liver in a developing country is responsible for significant liver disease","volume":"52","author":"Duseja","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2015.02.006_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.humpath.2009.06.021","article-title":"End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program","volume":"41","author":"Nayak","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jceh.2015.02.006_bib40","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.1840360609","article-title":"NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States","volume":"36","author":"Marrero","year":"2002","journal-title":"Hepatology"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2015.02.006_bib41","doi-asserted-by":"crossref","first-page":"A243","DOI":"10.1136\/gut.2011.239301.515","article-title":"NAFLD and the changing face of hepatocellular cancer (HCC) [Abstract]","volume":"60","author":"Das","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2015.02.006_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/gast.2002.34168","article-title":"Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma","volume":"123","author":"Bugianesi","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2015.02.006_bib43","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00535-008-2264-8","article-title":"Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo","volume":"43","author":"Abe","year":"2008","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib44","first-page":"45","article-title":"Is the prevalence of cryptogenic hepatocellular carcinoma increasing in Korea?","volume":"45","author":"Oh","year":"2005","journal-title":"Korean J Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3904\/kjim.2012.27.1.47","article-title":"Risk factors of cryptogenic hepatocellular carcinoma in patients with low body mass index or without metabolic syndrome","volume":"27","author":"Song","year":"2012","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jceh.2015.02.006_bib46","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2015.02.006_bib47","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1111\/j.1572-0241.2008.02188.x","article-title":"Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study","volume":"103","author":"McKimmie","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib48","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3748\/wjg.v11.i12.1848","article-title":"Hepatic steatosis is associated with an increased risk of carotid atherosclerosis","volume":"11","author":"Volzke","year":"2005","journal-title":"World J Gastronterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib49","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/01.ATV.0000160613.57985.18","article-title":"Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study","volume":"25","author":"Brea","year":"2005","journal-title":"Arterioscler Thromb Biol"},{"key":"10.1016\/j.jceh.2015.02.006_bib50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7869\/tg.2012.101","article-title":"Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease","volume":"34","author":"Guleria","year":"2013","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2015.02.006_bib52","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.2337\/dc07-0792","article-title":"Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men","volume":"30","author":"Shibata","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jceh.2015.02.006_bib53","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting Lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2015.02.006_bib54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jceh.2015.02.006_bib55","series-title":"Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation","author":"World Health Organization Department of Non-communicable Disease Surveillance","year":"1999"},{"key":"10.1016\/j.jceh.2015.02.006_bib56","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","article-title":"Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)","volume":"16","author":"Balkau","year":"1999","journal-title":"Diabet Med"},{"key":"10.1016\/j.jceh.2015.02.006_bib57","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2015.02.006_bib58","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc14-S014","article-title":"Standards of medical care in Diabetes\u20142014","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jceh.2015.02.006_bib59","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0899-9007(02)01083-3","article-title":"Non-obese (body mass index <25 kg\/m2) Asian Indians with normal waist circumference have high cardiovascular risk","volume":"19","author":"Vikram","year":"2003","journal-title":"Nutrition"},{"key":"10.1016\/j.jceh.2015.02.006_bib60","first-page":"345","article-title":"The metabolic syndrome in South Asians: continuing escalation & possible solutions","volume":"125","author":"Misra","year":"2007","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jceh.2015.02.006_bib61","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1665-2681(19)31822-8","article-title":"Metabolic syndrome and non-alcoholic fatty liver disease","volume":"8","author":"Almeda-Vald\u00e9s","year":"2009","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib62","first-page":"9","article-title":"Non alcoholic fatty liver disease and metabolic syndrome","volume":"13","author":"Paschos","year":"2009","journal-title":"Hippokratia"},{"key":"10.1016\/j.jceh.2015.02.006_bib63","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.20920","article-title":"Insulin resistance: a metabolic pathway to chronic liver disease","volume":"42","author":"Bugianesi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2015.02.006_bib64","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1463-1326.2004.00409.x","article-title":"The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study","volume":"7","author":"Athyros","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jceh.2015.02.006_bib65","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2015.02.006_bib66","first-page":"170","article-title":"Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease","volume":"26","author":"Duseja","year":"2007","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib67","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.3748\/wjg.v12.i21.3400","article-title":"Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians","volume":"12","author":"Madan","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib68","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4254\/wjh.v4.i7.209","article-title":"Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease","volume":"4","author":"Bhat","year":"2012","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib69","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2015.02.006_bib70","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1478-3231.2012.02820.x","article-title":"Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography","volume":"32","author":"de Ledinghen","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2015.02.006_bib71","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2015.02.006_bib72","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4103\/0377-4929.68246","article-title":"Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients","volume":"53","author":"Singh","year":"2010","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.jceh.2015.02.006_bib73","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s10620-007-0074-0","article-title":"Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis","volume":"53","author":"Singh","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2015.02.006_bib74","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.dsx.2010.07.004","article-title":"Non-alcoholic fatty liver disease in subjects with type 2 diabetes mellitus and non-diabetics with special reference to insulin resistance and hepatic histopathological changes","volume":"4","author":"Das","year":"2010","journal-title":"Diabetes Metab Syndr: Clin Res Rev"},{"key":"10.1016\/j.jceh.2015.02.006_bib75","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/0016-5085(90)91169-7","article-title":"Effect of weight reduction on hepatic abnormalities in overweight patients","volume":"99","author":"Palmer","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2015.02.006_bib76","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0168-8278(97)80287-5","article-title":"Therapeutic effects of restricted diet and exercise in obese patients with fatty liver","volume":"27","author":"Ueno","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib77","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa022637","article-title":"A\u00a0low-carbohydrate as compared with a low-fat diet in severe obesity","volume":"348","author":"Samaha","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2015.02.006_bib78","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1572-0241.2005.41334.x","article-title":"One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study","volume":"100","author":"Huang","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.293.1.43","article-title":"Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial","volume":"293","author":"Dansinger","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2015.02.006_bib80","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(01)06042-1","article-title":"Metformin in non-alcoholic steatohepatitis","volume":"358","author":"Marchesini","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2015.02.006_bib81","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2036.2004.01888.x","article-title":"Metformin in the treatment of patients with non-alcoholic steatohepatitis","volume":"19","author":"Uygun","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2015.02.006_bib82","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2036.2004.02025.x","article-title":"Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial","volume":"20","author":"Nair","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2015.02.006_bib83","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1572-0241.2005.41583.x","article-title":"A\u00a0randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease","volume":"100","author":"Bugianesi","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib84","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/00365520902845268","article-title":"Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial","volume":"44","author":"Haukeland","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib85","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1665-2681(19)31902-7","article-title":"Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions","volume":"6","author":"Duseja","year":"2007","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib86","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.20012","article-title":"A\u00a0pilot study of pioglitazone treatment for nonalcoholic steatohepatitis","volume":"39","author":"Promrat","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2015.02.006_bib87","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A\u00a0placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2015.02.006_bib88","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1542-3565(04)00457-4","article-title":"A\u00a0pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis","volume":"2","author":"Sanyal","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib89","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jceh.2012.10.010","article-title":"A\u00a0randomized controlled trial comparing efficacy of pentoxifylline and pioglitazone on metabolic factors and liver histology in patients with non-alcoholic steatohepatitis","volume":"2","author":"Sharma","year":"2012","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib90","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1046\/j.1365-2036.2001.01083.x","article-title":"Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study","volume":"15","author":"Hasegawa","year":"2001","journal-title":"Ailment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2015.02.006_bib91","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2015.02.006_bib92","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/hep.20092","article-title":"Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial","volume":"39","author":"Lindor","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2015.02.006_bib93","first-page":"1464","article-title":"Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study","volume":"23","author":"Laurin","year":"1996","journal-title":"Hepatology"},{"issue":"suppl 2","key":"10.1016\/j.jceh.2015.02.006_bib94","first-page":"A90","article-title":"A\u00a0pilot study of high dose of ursodeoxycolic acid (UDCA) in the treatment of nonalcoholic steatohepatitis [NASH]","volume":"26","author":"Singh","year":"2007","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib95","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jhep.2010.08.030","article-title":"A\u00a0randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis","volume":"54","author":"Ratziu","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib96","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/hep.23239","article-title":"Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial","volume":"50","author":"Abdelmalek","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2015.02.006_bib97","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/hep.20420","article-title":"Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis","volume":"40","author":"Yokohama","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2015.02.006_bib98","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/j.1572-0241.2004.40064.x","article-title":"A\u00a0pilot trial of pentoxifylline in nonalcoholic steatohepatitis","volume":"99","author":"Adams","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib99","first-page":"A330","article-title":"Pentoxifylline for treatment of non-alcoholic fatty liver disease (NAFLD): a randomized, placebo-controlled study [Abstract s2161]","author":"Buranawui","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2015.02.006_bib100","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1440-1746.2006.04756.x","article-title":"Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis","volume":"22","author":"Satapathy","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib101","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s12072-008-9058-1","article-title":"A\u00a0randomized controlled pilot study of pentoxifylline in patients with non-alcoholic steatohepatitis (NASH)","volume":"2","author":"Lee","year":"2008","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2015.02.006_bib102","first-page":"3","article-title":"S-adenosylmethionine (Heptral\u00ae) in treatment of patients with non-alcoholic steatohepatitis","volume":"1","author":"Baranovsky","year":"2010","journal-title":"Clin Perspect Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib103","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1365-2036.2006.02926.x","article-title":"A\u00a0pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients","volume":"23","author":"Gomez-Dominguez","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"1 Pt 1","key":"10.1016\/j.jceh.2015.02.006_bib104","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1440-1746.2005.04233.x","article-title":"Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis","volume":"21","author":"Sreenivasa Baba","year":"2006","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2015.02.006_bib105","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.23727","article-title":"High dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo controlled trial","volume":"52","author":"Leuschner","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2015.02.006_bib106","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0022-3476(00)05040-X","article-title":"Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study","volume":"136","author":"Lavin","year":"2000","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jceh.2015.02.006_bib107","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2015.02.006_bib108","first-page":"251","article-title":"Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease","volume":"24","author":"Madan","year":"2005","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2015.02.006_bib109","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/hep.22292","article-title":"Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease","volume":"47","author":"Dunn","year":"2008","journal-title":"Hepatology"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688315000353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688315000353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:02:49Z","timestamp":1760853769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688315000353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0973688315000353"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2015.02.006","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic Fatty Liver Disease and Metabolic Syndrome\u2014Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 INASL. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}